WRF Capital Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 9
- Investments
- 159
- Portfolio
- 41
- Exits
- 67
WRF Capital General Information
Description
Washington Research Foundation (WRF) is an independent non-profit foundation based in Seattle, Washington. Established in 1981, the foundation primarily focuses on technology in the life sciences, information technology, and physical sciences fields, arising from Washington State research institutions. The assets of the foundation are managed and administered by the board of directors.WRF Capital is the venture capital arm of the Washington Research Foundation and it specializes in early-stage investments. The firm focuses on investing in companies operating in life sciences and enabling technologies developing products arising from research at Washington State institutions.
Contact Information
Year Founded
1981
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 2815 Eastlake Avenue East
- Suite 300
- Seattle, WA 98102
- United States
+1 (206) 000-0000
WRF Capital Investments (159)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| BlueDot Photonics | 03-May-2021 | Seed Round | 000 | Alternative Energy Equipment | Product Development | |
| 0000000 | 14-Apr-2021 | 00000 00000 | 00.000 | Other Healthcare Technology Systems | Generating Revenue | 0000000 000000 |
| 0000000 | 02-Apr-2021 | 00000 00000 | 00.000 | Electrical Equipment | Generating Revenue | |
| 0000 0000000000000 | 31-Mar-2021 | 0000 00000 | 000.00 | Biotechnology | Stealth | |
| 0000000 000 | 31-Mar-2021 | 00000 00000 | 0000 | Drug Discovery | Startup | |
| 00000 000000000 | 18-Nov-2020 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | |
| 000000000 00000000 | 30-Jul-2020 | 0000 00000 | Drug Discovery | Generating Revenue | ||
| 00000000 | 16-Jul-2020 | 0000 00000 | 00.00 | Electronic Equipment and Instruments | Generating Revenue | |
| Medcurity | 13-Jul-2020 | Seed Round | 00.00 | Enterprise Systems (Healthcare) | Generating Revenue | |
| MDMetrix | 22-May-2020 | Seed Round | 00.000 | Outcome Management (Healthcare) | Generating Revenue |
WRF Capital Exits (67)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Lyell | 17-Jun-2021 | IPO | 00000 |
| 00000 000000000000 | 30-Mar-2021 | 000000000000000000 | 00000 |
| 0000 0000000000000 | 04-Feb-2021 | 000 | 00000 |
| 000000 000000 | 18-Sep-2020 | 000 | 00000 |
| 0000000000 | 23-Jun-2020 | 000000000000000000 | |
| 00000 | 31-Dec-2019 | 0000000000: 000000 | |
| 00000000 | 11-Dec-2019 | 000 00 00000000 | |
| 00000 000000000000 | 01-Nov-2019 | 000 00 00000000 | |
| Phytelligence | 27-Sep-2019 | Out of Business | |
| Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) | 08-Aug-2019 | Merger/Acquisition | 000.00 |
WRF Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialWRF Capital Team (11)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Jeff Eby | Chief Financial Officer | Seattle, WA | |||
| Loretta Little | Managing Director | 00 | 0 | Seattle, WA | |
| William Canestaro Ph.D | Managing Director | 0 | Seattle, WA | ||
| Morgan Hellar | Controller | Seattle, WA | |||
| Dale Wadman | Communications Manager | Seattle, WA |
WRF Capital Co-Investors (143)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alliance of Angels | 6 | 0 | 0 |
|
|
| The W Fund | 0 | 0 | 0 |
|
|
| ARCH Venture Partners | 0 | 0 | 0 |
|
|
| Alexandria Venture Investments | 0 | 0 | 0 |
|
|
| WuXi AppTec | 0 | 0 |
|
|